UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050874
Receipt number R000051187
Scientific Title Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial
Date of disclosure of the study information 2023/04/19
Last modified on 2023/04/18 09:22:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial

Acronym

Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial

Scientific Title

Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial

Scientific Title:Acronym

Daily use of Duloxetine is effective in treating premature ejaculation: A prospective randomized placebo-controlled crossover clinical trial

Region

Africa


Condition

Condition

male sexual function

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Daily use of Duloxetine effect in treating premature ejaculation

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

improvement in premature ejaculation

Key secondary outcomes

impact on sexual function and quality of life


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

34 patients will receive duloxetine then placebo in group A

Interventions/Control_2

34 patients will receive placebo then duloxetine in group B

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >=

Gender

Male

Key inclusion criteria

Male patients with PE (primary or secondary) with stable and committed relationship having (IELT) < 2 minutes were included

Key exclusion criteria

Patients with erectile dysfunction (ED), reduced sexual desire or inhibited male orgasm or active genitourinary tract infection (confirmed by two glasses of urine and EPS) or known mental disorders (Depression, Anxiety, Schizophrenia) or uncontrolled physical illnesses (Hepatic, Renal, Cardiac, Neurological, Endocrinal) were excluded from the study. Finally, any alcohol or drug abuser or patient with known hypersensitivity to duloxetine was excluded from the study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name sameh
Middle name fayek
Last name gamalel din

Organization

kasr AlAiny faculty of medicine Cairo university

Division name

Andrology & STDs

Zip code

002

Address

357 C south academy New Cairo

TEL

01227109309

Email

samehfayek@hotmail.com


Public contact

Name of contact person

1st name sameh
Middle name fayek
Last name gamalel din

Organization

Kasr AlAiny faculty of medicine

Division name

Andrology & STDs

Zip code

002

Address

357 C south academy New Cairo

TEL

01227109309

Homepage URL

http://scholar.cu.edu.eg/sfayek

Email

samehfayek@hotmail.com


Sponsor or person

Institute

Kasr AlAiny faculty of medicine

Institute

Department

Personal name



Funding Source

Organization

Kasr AlAiny faculty of medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Egypt


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Cairo University, Faculty of medicine, Cairo, Egypt

Address

357 C south academy New Cairo

Tel

+20 25 729 584

Email

samehfayek@hotmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 19 Day


Related information

URL releasing protocol

Duloxetine is effective and safe in patients with primary and secondary premature ejaculation

Publication of results

Unpublished


Result

URL related to results and publications

Duloxetine is effective and safe in patients with primary and secondary premature ejaculation

Number of participants that the trial has enrolled

100

Results

Duloxetine is effective and safe in patients with primary and secondary premature ejaculation

Results date posted

2023 Year 04 Month 18 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Duloxetine is effective and safe in patients with primary and secondary premature ejaculation

Participant flow

Duloxetine is effective and safe in patients with primary and secondary premature ejaculation

Adverse events

Nausea was the main side effect reported

Outcome measures

Duloxetine is effective and safe in patients with primary and secondary premature ejaculation

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 04 Month 24 Day

Date of IRB

2022 Year 04 Month 24 Day

Anticipated trial start date

2022 Year 05 Month 17 Day

Last follow-up date

2022 Year 08 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 04 Month 18 Day

Last modified on

2023 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051187


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name